M1 MUSCARINIC ANTAGONISTS INTERACT WITH SIGMA-RECOGNITION SITES

被引:53
作者
HUDKINS, RL
DEHAVENHUDKINS, DL
机构
[1] STERLING RES GRP,DEPT ENZYMOL & RECEPTOR BIOCHEM,25 GREAT VALLEY PKWY,MALVERN,PA 19355
[2] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,SCH PHARM,DEPT MED CHEM,RICHMOND,VA 23298
关键词
D O I
10.1016/0024-3205(91)90135-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The M1-selective muscarinic antagonists aprophen, caramiphen, carbetapentane, 2-DAEX, dicyclomine, hexahydrosiladifenidol, iodocaramiphen, nitrocaramiphen, oxybutynin and trihexyphenidyl potently inhibited binding to sigma-sites in brain. Both basic ester and non-ester structural type compounds which exhibit affinity for the muscarinic receptor also demonstrated affinity for the sigma-site, while the classical antimuscarinic agents atropine and QNB, and the tricyclic pirenzepine, were ineffective in binding to this site. We also observed a significant correlation between the K(i) values for sigma-compounds to inhibit [H-3]pirenzepine binding and their IC50 values to inhibit carbachol-stimulated phosphoinositide turnover. These observations may aid in elucidating the relationship of sigma-binding to inhibition of phosphoinositide turnover stimulated by cholinergic agonists.
引用
收藏
页码:1229 / 1235
页数:7
相关论文
共 33 条
[21]  
SIRCAR R, 1986, J PHARMACOL EXP THER, V237, P681
[22]  
STUBBINS JF, 1972, J PHARM SCI, V3, P470
[23]  
SU TP, 1982, J PHARMACOL EXP THER, V223, P284
[24]   EFFECTS OF ANTIPARKINSONIAN DRUGS ON MUSCARINIC RECEPTOR-BINDING IN RAT-BRAIN, HEART AND LUNG [J].
SYVALAHTI, EKG ;
KUNELIUS, R ;
LAUREN, L .
PHARMACOLOGY & TOXICOLOGY, 1988, 62 (02) :90-94
[25]  
Tallarida R.J., 1987, MANUAL PHARM CALCULA
[26]   SIGMA-OPIATES AND CERTAIN ANTIPSYCHOTIC-DRUGS MUTUALLY INHIBIT (+)-[H-3]SKF-10,047 AND [H-3]HALOPERIDOL BINDING IN GUINEA-PIG BRAIN MEMBRANES [J].
TAM, SW ;
COOK, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (17) :5618-5621
[27]  
TAYLOR D P, 1990, Society for Neuroscience Abstracts, V16, P588
[28]   BINDING-AFFINITY AND ANTIMUSCARINIC ACTIVITY OF SIGMA AND PHENCYCLIDINE RECEPTOR LIGANDS [J].
VARGAS, HM ;
PECHNICK, RN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 195 (01) :151-156
[29]  
WALKER JM, 1990, PHARMACOL REV, V42, P355
[30]  
WATSON M, 1986, J PHARMACOL EXP THER, V237, P411